Structural changes of the ligand and of the receptor alters the receptor preference for neutrophil activating peptides starting with a formylmethionyl group
Huamei Forsman(Harvard University), Cláes Dahlgren(Centre for Inflammation Research), Malene Winther(University of Gothenburg), Marie‐Josèphe Rabiet(Centre National de la Recherche Scientifique), François Boulay(Université Grenoble Alpes), Sarah Line Skovbakke(University of Copenhagen), Michael Gabl(University of Gothenburg)
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
October 30, 2014
Cited by 41
Related Papers
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
|Pharmacological Reviews|2009|770
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils.
|The Journal of Immunology|1995|314
Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes
|Infection and Immunity|1983|244